Advisers to the Food and Drug Administration are scheduled to meet in March on influenza vaccines, the agency said on Feb. 25.
The FDA’s Vaccines and Related Biological Products Advisory Committee will meet on March 12 “to discuss and make recommendations on the strain composition of influenza virus vaccines for use in United States during the 2026-2027 influenza season,” the FDA said on its website.





